Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LRCX vs GSK✓SelectedUSD · GSKLRCX vs GSK performance historyLatest closeAs of-3.36%11/13
Stock and ETF performance explorer

LRCX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+277.1%
GSK return
+44.4%
Excess return
+232.7%
Maximum drawdown
-57.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.4%+0.5%-3.9%-3.4%
7D+12.7%+1.1%+11.6%+12.6%
30D-21.3%+6.3%-27.6%-21.8%
3M-32.9%+1.8%-34.7%-33.2%
6M-23.4%+1.7%-25.0%-24.1%
YTD+32.4%+6.5%+25.8%+30.3%
1Y+48.0%+9.5%+38.5%+44.8%
3Y+243.9%+65.3%+178.6%+204.5%
All+277.1%+44.4%+232.7%+227.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling